← All trials
NCT02311855
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2014
- Primary completion
- Dec 1, 2015
- Completion date
- Feb 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 87
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Bassett HealthcareLead sponsor
- Bassett HealthcareOverall official - principal investigator
- Bassett HealthcareReponsible party - principal investigator
- State of New YorkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.